Results 11 to 20 of about 465,082 (214)
Quantum meet-in-the-middle attack on Feistel construction
Quantum Information Processing, 2023 18 pages, 3 ...
Yinsong Xu 0002, Zheng Yuan
openaire +3 more sources
A Meet-in-the-Middle Attack on 8-Round AES [PDF]
, 2008 We present a 5-round distinguisher for AES. We exploit this distinguisher to develop a meet-in-the-middle attack on 7 rounds of AES-192 and 8 rounds of AES-256. We also give a time-memory tradeoff generalization of the basic attack which gives a better balancing between different costs of the attack.
Hüseyin Demirci, Ali Aydin Selçuk
openaire +3 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen +23 more
wiley +1 more source
Meet-in-the-Middle Attacks on Reduced-Round XTEA [PDF]
, 2011 Summary: The block cipher GOST (GOST 28147-89) is a Russian standard for encryption and message authentication that is included in OpenSSL 1.0.0. In this paper, we present meet-in-the-middle attacks on several block ciphers, each consisting of 22 or fewer rounds of GOST.
Sekar, Gautham +3 more
openaire +3 more sources
A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho +7 more
wiley +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye +33 more
wiley +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Patients with chronic kidney disease undergoing hemodialysis commonly experience reduced physical function, fatigue, poor sleep quality, and impaired health‐related quality of life. Intradialytic exercise has been proposed as a non‐pharmacological strategy to improve these outcomes.
Klebson da Silva Almeida +6 more
wiley +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola +4 more
wiley +1 more source
Meet in the Middle: A New Pre-training Paradigm
Advances in Neural Information Processing Systems 36, 2023 Most language models (LMs) are trained and applied in an autoregressive left-to-right fashion, assuming that the next token only depends on the preceding ones. However, this assumption ignores the potential benefits of using the full sequence information during training, and the possibility of having context from both sides during inference.
Anh Nguyen +2 more
openaire +3 more sources
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Maintenance hemodialysis (MHD) patients frequently suffer from frailty, characterized by reduced physical function and poor prognosis. Myokines, such as myonectin, secreted by muscle, are emerging regulators of systemic health. This study investigated the relationship between serum myonectin, adipokines (adiponectin, omentin), and ...
Kenichi Kono +7 more
wiley +1 more source